Mohr Marketing Launches “Post-Settlement” Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket Control

Mohr Marketing, a specialized digital agency for the legal sector, today announced the launch of its “Tier 1” Bard Intake Protocol, a proprietary acquisition program designed specifically for the post-settlement administration phase of the C.R. Bard Hernia Mesh litigation (MDL No. 2846).

Following Becton Dickinson’s global settlement framework of approximately $1.9 billion announced in late 2024, the litigation landscape has shifted from volume accumulation to strict docket management. With the court now implementing rigorous “Lone Pine” style evidentiary standards, law firms face increasing pressure to filter out non-meritorious claims before they reach the filing stage.

Mohr Marketing’s new protocol addresses this industry-wide challenge by utilizing AI WebTracker® technology to pre-qualify claimants based on confirmed revision surgery and product identification, ensuring that partner firms acquire only those assets that meet the 2026 settlement matrix criteria.

Solving the “Inventory Padding” Crisis

The days of ‘sign-and-hold’ are over for the Bard docket. In 2026, a case without a confirmed revision surgery isn’t just a low-value asset—it is a liability. Our new protocol is engineered to act as a firewall, rejecting ‘pain-only’ leads at the source, so our partner firms can focus their resources on administering high-value claims.

Key Features of the 2026 Protocol:

• Surgical Verification: Automated filtering that disqualifies claimants who have not undergone revision or removal surgery.
• Evidence Retrieval: Front-loaded screening for operative reports and implant cards to satisfy “Proof of Use” requirements.
• Statute Compliance: targeted acquisition of “Late Discovery” claimants to ensure statute of limitations viability in a mature tort.

New “Revision-Only” Acquisition Strategy Designed to eliminate “Inventory Bloat” for Mass Tort Firms in MDL 2846

Let’s discuss your specific needs and how our Compliance Program, AI Lead Generation Technology, digital marketing, and mass tort cases can help you achieve your growth goals.

Contact Mohr Marketing today for a custom quote

www.mohrmktg.com 

Best Wishes,
Sue Mohr

Summary

Article Name

Mohr Marketing Launches "Post-Settlement" Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket Control

Description

Mohr Marketing, a specialized digital agency for the legal sector, today announced the launch of its "Tier 1" Bard Intake Protocol, a proprietary acquisition program designed specifically for the post-settlement administration phase of the C.R. Bard Hernia Mesh litigation (MDL No. 2846).

Author

Susan Mohr

Publisher Name

Mohr Marketing, LLC

Publisher Logo